Zesong Li

17.2k citations
243 papers · 5.0k indexed · 1 hit paper · h-index 37
Topics
Neuroscience and Neuropharmacology Research (21 papers)Adenosine and Purinergic Signaling (18 papers)RNA modifications and cancer (12 papers)

In The Last Decade

Zesong Li

232 papers receiving 4.9k citations

Hit Papers

MULLS: Versatile LiDAR SLAM via Multi-metric Linear Least...2021202620222024202150100150

Peers

Zesong Li
Comparison fields: 5 of 179
  • Molecular Biology 2.4k
  • Cancer Research 858
  • Cellular and Molecular Neuroscience 480
  • Physiology 399
  • Oncology 381
Replace Jing Chen with:
Jing Chen China
Youyi Zhang China
P. Mêda Switzerland
Jing Zhang China
Xiaolei Zhang China
Katsuhiro Tanaka Japan
Young‐Bum Kim United States
Tae Soo Kim South Korea
Xiaobo Wang China
David S. Salomon United States
Zesong Li relative to Jing Chen China Jing Chen's profile →
Citations per field
00.5×3.4×
Jing Chen · 1×
Citations per year

Countries citing papers authored by Zesong Li

Since Specialization
Citations

This map shows the geographic impact of Zesong Li's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Zesong Li with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Zesong Li more than expected).

Fields of papers citing papers by Zesong Li

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Zesong Li. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Zesong Li. The network helps show where Zesong Li may publish in the future.

Co-authorship network of co-authors of Zesong Li

This figure shows the co-authorship network connecting the top 25 collaborators of Zesong Li. A scholar is included among the top collaborators of Zesong Li based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Zesong Li. Zesong Li is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
#WorkIndexed citations
1 1
2 2
3 8
4 4
5 0
6 13
7 18
8 8
9 21
10 10
11 4
12 6
13 21
14 131
15 3
16 48
17 33
18 201
19 9
20 58

About Zesong Li

Zesong Li is a scholar working on Physiology, Cancer Research and Endocrine and Autonomic Systems, having authored 243 papers that have together received 5.0k indexed citations. Recurring topics across this work include Neuroscience and Neuropharmacology Research (21 papers), Adenosine and Purinergic Signaling (18 papers) and RNA modifications and cancer (12 papers). The work is most often cited by research in Physiology (399 citations), Cancer Research (858 citations) and Endocrine and Autonomic Systems (248 citations). Zesong Li has collaborated with scholars based in China, United States and Hong Kong. Frequent co-authors include Suzanne L. Mansour, Forrest F. Weight, Robert W. Peoples, Qin Ru, Zhiming Cai, Lin Chen, Keming Xiong, Ekaterina Hatch, Daryl A. Scott and Xiaoyan Tian. Their work appears in journals such as Journal of Biological Chemistry, Genes & Development and PLoS ONE.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026